Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Asymmetrex has raised $1.8M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Asymmetrex's investors include National Heart, Lung and Blood Institute.
Asymmetrex is headquartered in Boston, United States.
Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Asymmetrex is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asymmetrex — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/asymmetrex. Accessed October 6, 2026.
VCBacked. (2024). Asymmetrex — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/asymmetrex
{{cite web |title=Asymmetrex — Funding & Investors |url=https://www.vcbacked.co/company/asymmetrex |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated